Striatal D<sub>2</sub> receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with <sup>11</sup>C‐raclopride and positron emission tomography
抄録
<jats:title>Abstract</jats:title><jats:p>Equilibrium striatal: cerebellar <jats:sup>11</jats:sup>C‐raclopride (RAC) uptake ratios reflect the density of striatal dopamine D<jats:sub>2</jats:sub> binding sites. Using positron emission tomographic scanning we have measured striatal RAC uptake in 6 untreated patients with Parkinson's disease (PD), 5 chronically treated patients with PD and a fluctuating response to <jats:sc>L</jats:sc>‐dopa, 10 patients with striatonigral degeneration (SND), and 9 patients with progressive supranuclear palsy (PSP). Regional cerebral blood flow was determined also, with C<jats:sup>15</jats:sup>O<jats:sub>2</jats:sub>. Mean strital: cerebellar RAC uptake was not significantly different from normal in untreated patients with PD, though 2 of these 6 patients showed significantly increased putamen tracer binding. Mean caudate and putamen: cerebellar RAC uptake ratios of the group with PD and fluctuating response to <jats:sc>L</jats:sc>‐dopa were significantly reduced by 30% and 18%, respectively. The patients with SND had lesser, but significant, 10% and 11% decreases in mean caudate and putamen: cerebellar RAC uptake ratios, respectively, whereas patients with PSP showed 24% and 9% reductions in caudate and putamen: cerebellar RAC binding. Striatal and frontal blood flow were significantly reduced in patients with PSP, but not in patients with PD or SND. In conclusion, striatal D<jats:sub>2</jats:sub> binding potential is normal or raised in untreated patients with PD, but reduced in patients with PD and a fluctuating response to <jats:sc>L</jats:sc>‐dopa. Patients with SND and PSP show a decrease in striatal RAC binding, but to a lesser extent than patients with PD and a fluctuating response to treatment. Failure of patients with SND and PSP to respond well to <jats:sc>L</jats:sc>‐dopa cannot therefore be due to losss of striatal D<jats:sub>2</jats:sub> sites alone, but must reflect loss of other basal ganglia connections.</jats:p>
収録刊行物
-
- Annals of Neurology
-
Annals of Neurology 31 (2), 184-192, 1992-02
Wiley
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1360011144549415296
-
- NII論文ID
- 30008832543
-
- ISSN
- 15318249
- 03645134
-
- データソース種別
-
- Crossref
- CiNii Articles